Advances of Particle Therapy in Prostate Cancer
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 10 September 2024 | Viewed by 1414
Special Issue Editor
Special Issue Information
Dear Colleagues,
Prostate cancer is the most prevalent cancer among men in the United States. Radiation therapy has been one of the major treatment options for prostate cancer. Recent technical advances in external beam RT using photons—for example, SBRT and IMRT—have permitted the delivery of a higher dose to tumors and a lower dose to surrounding tissues. At the same time, basic and clinical research into external RT using particles (particle RT) has been carried out for the purpose of establishing more effective and non-invasive treatments. Among the particles used in such treatments, protons and carbon ions are the ones most commonly used. New technologies and clinical approaches have been developed to improve therapies. This Special Issue aims to introduce recent advances and breakthroughs in the particle treatment of prostate cancer. Submissions of communications, full papers, mini-reviews, and reviews are all welcomed. We look forward to your contributions and fruitful discussions.
Dr. Xinning Wang
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- prostate cancer
- particle therapy
- radiation therapy
- diagnose
- treatment
- SBRT
- IMRT